Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $458M invested in Amphastar Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.3% less ownership
Funds ownership: 48.21% → 47.91% (-0.3%)
Holders
135
Holding in Top 10
–
Calls
$221K
Puts
–
Top Buyers
| 1 | +$3.48M | |
| 2 | +$3.08M | |
| 3 | +$2.69M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.4M |
| 5 |
Goldman Sachs
New York
|
+$1.67M |
Top Sellers
| 1 | -$5.03M | |
| 2 | -$2.57M | |
| 3 | -$2.45M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.43M |
| 5 |
BlackRock
New York
|
-$1.77M |